BioStem Technologies, Inc. ( BSEM) - Key Metrics
BSEM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.63 | $0.05 | -$0.14 | -$0.29 |
| 2025Q2 | $2.95 | -$0.03 | $0.32 | $0.30 |
| 2025Q1 | $2.75 | $0.17 | $0.15 | $0.15 |
BSEM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | 25.80 |
| 2025Q2 | ? | -95.11 |
| 2025Q1 | ? | 12.65 |
BSEM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 3.75% | ? |
| 2025Q3 | -6.11% | ? |
| 2025Q2 | 2.37% | ? |
| 2025Q1 | 2.74% | ? |
BSEM
Price: $4.12
52 week price:
Earnings Per Share: 0.88 USD
P/E Ratio: 4.69
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 69.5 million